
India rejects European FTA bloc's 'data exclusivity' demand to protect generic drug firms' interest
The Hindu
India rejects demand for 'data exclusivity' provision in free trade agreements with European nations, protecting domestic generic drugs industry.
India on Thursday said it has rejected the demand of the four European nations EFTA bloc for inclusion of a 'data exclusivity' provision in proposed free trade agreements, stating that it always protects the interests of the domestic generic drugs industry.
Commerce Secretary Sunil Barthwal said there is no Free Trade Agreement (FTA) in which India will go against the generic drug industry.
The European Free Trade Association (EFTA) members are Iceland, Liechtenstein, Norway, and Switzerland. The bloc is negotiating a trade agreement with India.
“They want that there should be data exclusivity, we rejected their demand. We are with our generic industry.”
Also Read | Optimistic on trade agreement ahead of elections: Swiss, Norway Ministers
"There is no fear for Indian generic industry (from this agreement). In fact, it is our very important objective to see that generic drug industry flourishes," he told reporters in Delhi.
The Secretary said the industry is contributing significantly to India's exports, which are also growing.

Scaling Artificial Intelligence(AI) at the speed at which consultants project is not possible by the laws of physics and may not be environmentally sustainable, said Tanvir Khan, who is the Executive Vice President and Chief Operating Officer of NTT DATA North America, part of the Japanese technology services and data centre company NTT Data, in an interview with The Hindu.












